1. Home
  2. GLNG vs VTAK Comparison

GLNG vs VTAK Comparison

Compare GLNG & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golar Lng Ltd

GLNG

Golar Lng Ltd

HOLD

Current Price

$55.06

Market Cap

4.1B

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.09

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLNG
VTAK
Founded
1946
2002
Country
Bermuda
United States
Employees
N/A
22
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
2.6M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
GLNG
VTAK
Price
$55.06
$1.09
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$50.63
N/A
AVG Volume (30 Days)
3.1M
756.6K
Earning Date
11-21-2023
05-13-2026
Dividend Yield
1.85%
N/A
EPS Growth
N/A
89.53
EPS
N/A
N/A
Revenue
N/A
$442,000.00
Revenue This Year
$3.55
$822.86
Revenue Next Year
$7.26
$168.42
P/E Ratio
$80.48
N/A
Revenue Growth
N/A
3057.14
52 Week Low
$29.56
$0.15
52 Week High
$55.80
$4.31

Technical Indicators

Market Signals
Indicator
GLNG
VTAK
Relative Strength Index (RSI) 72.62 32.36
Support Level $39.64 $0.15
Resistance Level N/A $2.08
Average True Range (ATR) 1.74 0.14
MACD 0.73 -0.02
Stochastic Oscillator 94.19 3.67

Price Performance

Historical Comparison
GLNG
VTAK

About GLNG Golar Lng Ltd

Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: